Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Close-field electroporation gene delivery for damaged cochlear hair cells regeneration

May 29, 2014

Novartis plans phase I/II study of CGF-166

May 15, 2014

Oricula Therapeutics receives NIH grant to further develop medicine to preserve hearing

May 2, 2014

Oricula Therapeutics secures intellectual property and funding to prevent hearing loss

April 10, 2014

Amarantus acquires option to license intellectual property for MANF and CDNF

March 10, 2014

Auris Medical enrolls first patient in European study of AM-101 in peripheral tinnitus

Feb. 25, 2014

Third milestone achieved in GenVec and Novartis collaboration

Feb. 17, 2014

Audion Therapeutics and Lilly to develop hearing loss treatments

Feb. 11, 2014

New potassium channel modulators patented by Autifony Therapeutics

Dec. 16, 2013

Otonomy's OTO-201 reduces treatment failure in subjects undergoing ear tube placement surgery

Aug. 21, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...